Guardant Health (GH) Tops Q4 EPS by 16c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Guardant Health (GH) PT Raised to $60 at BTIG
February 21, 2025 6:19 AM ESTBTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $55.00) while maintaining a Buy rating.
The analyst comments "Guardant had an excellent 2024 and investor sentiment has significantly shifted positive (rightly so, in our view) as the... More
